Winetsky DE, Myers J, Schulz S, Tino G, Wilck M.: A Case of Cavitary Pulmonary Mycobacterium Avium Intracellulare Infection in the Setting of Leflunomide Treatment.
J Clin Rheumatol 23 (4): 231-232,2017.
Costa-Reis P, Russo PA, Zhang Z, Colonna L, Maurer K, Gallucci S, Schulz SW, Kiani AN, Petri M, Sullivan KE: The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis Arthritis and Rheumatism 67 (9): 2415-26,2015.
Schulz SW, Shenin M, Mehta A, Kebede A, Fluerant M, Derk CT: Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases Rheumatology International 32 (9): 2623-7,2012.
Haija AJ, Schulz SW.: The role and effect of complementary and alternative medicine in systemic lupus erythematosus.
Rheum Dis Clin North Am. 37 (1): 47-62,2011.
Schulz SW, Bober M, Johnson C, Braverman N, Jimenez SA.: Maternal mixed connective tissue disease and offspring with chondrodysplasia punctata. Semin Arthritis Rheum. 39 (5): 410-6,2010.
Derk CT, Grace E, Shenin M, Naik M, Schulz S, Xiong W.: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis. Rheumatology (Oxford) 48 (12): 1595-9,2009.
Schulz SW, O'Brien M, Maqsood M, Sandorfi N, Del Galdo F, Jimenez SA.: Improvement of severe systemic sclerosis-associated gastric antral vascular ectasia following immunosuppressive treatment with intravenous cyclophosphamide. J Rheumatol. 36 (8): 1653-6,2009.
Schulz SW, Derk CT.: Gastrointestinal Manifestation of Systemic Lupus Erythematosus: a survey of literature. Open Rheumatol J. 1 : 10-26,2009.
Schulz SW, Derk CT.: Systemic sclerosis at the cellular level: molecular pathways of pathogenesis and its implication on future drug design. Curr Med Chem. 16 (30): 3986-95,2009.
Shenin M, Schulz SW, Derk CT: Improvement of pulmonary function studies in patients with early diffuse systemic sclerosis without clinical symptoms of pulmonary involvement six months after initiation of mycophenolate mofetil: a prospective open label study. ACR National Meeting, San Francisco, CA